SEGMENT INFORMATION

9 Months Ended

Apr. 30, 2014

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes for the three and nine months ended April 30, 2014 and April 30, 2013.

	Three Months Ended				Nine Months Ended
	Apr 30, 2014		Apr 30, 2013		Apr 30, 2014		Apr 30, 2013
SALES:
Life Sciences	$	368,835	$	326,097	$	1,041,011	$	955,230
Industrial	313,610		315,093		948,182		976,015
Total	$	682,445	$	641,190	$	1,989,193	$	1,931,245
SEGMENT PROFIT:
Life Sciences	$	88,339	$	81,195	$	252,240	$	233,514
Industrial	49,350		45,853		146,723		146,723
Total segment profit	137,689		127,048		398,963		380,237
Corporate Services Group	17,304		15,172		48,034		47,263
ROTC	11,542		12,824		29,910		21,497
Interest expense, net	4,747		5,298		15,919		10,747
Earnings from continuing operations before income taxes	$	104,096	$	93,754	$	305,100	$	300,730